VBS is excited to bring you a series of virtual retina activities intended to bring the VBS community together to discuss the most exciting surgeries and developments in our field. The virtual series format will include speakers and panelists with robust discussion and an interactive format whereby audience members are encouraged to participate.
Part Two: June 24, 2020
Part Three: July 29, 2020
Part Four: August [TBA]
The VBS Annual Meeting returns in a social distancing- compliant fashion with VBS 8: Virtual Series Part One, featuring a discussion of COVID-19 impact on academic and private retina institutions, pearls for subretinal gene therapy surgery and pneumatic retinopexy, first-time presentation of clinical trial results, and classic surgical debate.
COVID-19 Impact in NYC
Practice Management during the COVID-19 Pandemic
Thinking Outside the Bubble with Pneumatic Retinopexy
Subretinal Gene Therapy Surgery
Medical Retina Highlights
1. A Novel Tyrosine Kinase Inhibitor Hydrogel Intravitreal Implant (OTX-TKI): First Time Data Release
2. Delivering Anti-VEGF Pharmacotherapy with Gene Therapy: Update on Clinical Trial Data
ILM Peeling for RRD Debate, PRO
ILM Peeling for RRD Debate, CON